News
Hot off the Press
Discover news about Xcellerant Ventures, portfolio companies and the industry landcape.
Xcellerant Ventures News
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Portfolio Company News
TruLite Health Selected for Microsoft Pegasus Program
Origionally posted on TruLite Health website: https://trulitehealth.com/trulite-health-selected-for-microsoft-for-startups-pegasus-program/ TEMPE, ARIZ. (October 03, 2024) – TruLite Health, developer of the only health equity solution to remediate clinical bias, is...
Xcellerant Ventures Leads DeepLook Medical’s Series A Round
Origionally posted on Business Wire: https://www.businesswire.com/news/home/20240924360690/en/Xcellerant-Ventures-Leads-DeepLook-Medical%E2%80%99s-Series-A-Round SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Xcellerant Ventures is proud to announce that it will lead DeepLook...
DeepLook Medical’s DL Precise™ improved the performance of the breast imaging department with 12% favorable change in recall rates
Origionally posted on DeepLook Medical's Website: https://www.deeplookmedical.com/post/deeplook-medical-s-dl-precise-improved-the-performance-of-the-breast-imaging-department-with-12-fa Finding cancer in a mammogram is difficult, especially with women who have...
Feasibility Study Evaluates Potential of Digital Health Platform to Help Patients Manage Prostate Cancer Symptoms
Origionally posted on Health Innovation Oxford's website: https://www.healthinnovationoxford.org/our-work/strategic-and-industry-partnerships-2/economic-growth-case-studies/digital-health-oncology-platform-supports-better-outcomes-for-prostate-cancer-patients/ ...
CRISPR QC Launches Three Innovative Products and Unveils Revamped Website
Origionally posted on EIN Presswire: https://www.einpresswire.com/article/710284206/lenoss-medical-oversubscribes-4-million-series-a-financing SAN DIEGO--(BUSINESS WIRE)--CRISPR QC, a pioneering biotechnology company in San Diego, is excited to announce the...
In vitro CRISPR-Cas Cleavage Assays Streamline Gene Editing Workflows
Origionally posted on CRISPR QC's website: https://crisprqc.com/wp-content/uploads/2024/08/20240806-CRISPR-Cleave-Case-Study-Layout.pdf Key Takeaways: CRISPR QC’s in vitro CRISPR-Cas cleavage assays can streamline CRISPR workflows by identifying optimal gRNAs...
Optimizing Ribonucleoprotein (RNP) Complexes and Improving Multiplex Gene Editing Efficiency with Data-Driven gRNA Selection
Origionally posted on CRISPR QC's website: https://crisprqc.com/wp-content/uploads/2024/08/20240806-CRISPR-RNP-Case-Study-Layout.pdf Key Takeaways: A critical gap exists in the CRISPR workflow: the lack of an in vitro QC step. The CRISPR Analytics Platform is...
Accelerating CRISPR-Cas Optimization with Quantitative DNA Binding Analysis
Origionally posted on CRISPR QC's website: https://crisprqc.com/wp-content/uploads/2024/08/20240806-CRISPR-DNA-Case-Study-Layout.pdf Key Takeaways: The CRISPR Analytics Platform is an in vitro tool for measuring CRISPR editing efficiency, as well as, RNP...
Wave Health Named a 2024 ASCO Breakthrough Abstract Award Winner
Origionally posted on TTI's website: https://tti.care/2024-asco-breakthrough-abstract-award-winner/ Recognized by Conquer Cancer®, the ASCO® Foundation, and the 2024 ASCO® Breakthrough Program Committee, Prestigious Award Recognizes Top Scoring Study Abstracts...
Bristol Resident’s Company Develops ‘Game Changing’ Product for Spinal Fractures
Origionally posted on EIN Presswire: https://www.einpresswire.com/article/710284206/lenoss-medical-oversubscribes-4-million-series-a-financing Dom Messerli isn’t an M.D., but based on his success in the medical device field so far, he knows how to fix a spine. He’s a...
AdviNOW Featured in Gartner Hype Cycle for Digital Clinical Encounters for Fourth Consecutive Year
Origionally posted on AdviNOW Medical's website: https://advinow.com/advinow-featured-in-gartner-hype-cycle-for-digital-clinical-encounters-for-fourth-consecutive-year/ We are thrilled to announce that AdviNOW has been recognized in the Gartner Hype Cycle for...
Unlocking the Power of CRISPR Technology for Drug Development with Ross Bundy CRISPR QC
Origionally posted on Empowered Patient Podcast: https://empoweredpatientradio.com/unlocking-the-power-of-crispr-technology-for-drug-development-with-ross-bundy-crispr-qc Ross Bundy, President and CEO of CRISPR QC, shines a light on the current state of CRISPR...
Why Xcellerant Ventures
We firmly believe that founders deserve more than just a check. In fact, investors should empower founds to help promote a vibrant ecosystem that allows groundbreaking ideas to enhance accessibility, efficiency, affordability, and quality of healthcare.
Futhermore, our GPs’ experience is unique and perfectly aligned with the needs of the market. They bring a combined experience of over seven decades in medical technologies, law, and entrepreneurship.
Through their personal experience, domain expertise, and unique network, they provide hands-on advice, education, and invaluable guidance to xcellerate startups and drive their success.
Founder Focus
We believe that the quality of the founders makes a huge difference in creating and fostering a successful partnership. We pick founders that are humble, willing to take advice, lead from the front, and are driven to change the world.
Moreover, we actively seek out founders and companies that have been overlooked by other venture capitalists, providing opportunities, expertise, and funding to individuals who have been traditionally underrepresented in the innovation economy.